![Juha Matti Yrjänheikki](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Juha Matti Yrjänheikki
Chief Executive Officer at Aurealis Oy
Juha Matti Yrjänheikki active positions
Companies | Position | Start | End |
---|---|---|---|
Aurealis Oy
![]() Aurealis Oy BiotechnologyHealth Technology Aurealis Oy operates as a biopharmaceutical company which develops treatment method that improves life for chronic inflammation and cancer sufferers. It develops a proprietary technology, which utilizes genetically modulated probiotics that deliver a variety of therapeutic proteins to diseased tissue, thus modulating local immune system and enabling healing. The company was founded by Dirk Weber and Thomas Wirth in 2010 and is headquartered in Kuopio, Finland. | Director/Board Member | 31/12/2020 | - |
Chief Executive Officer | 31/05/2013 | - | |
Nostetta Oy
![]() Nostetta Oy Investment ManagersFinance Nostetta Oy (Nostetta) is a venture capital firm founded in 2013. The firm is headquartered in Kuopio, Finland. | Director/Board Member | - | - |
Chairman | 31/05/2016 | - | |
Private Equity Investor | 31/05/2016 | - | |
Osuuskunta KPY
![]() Osuuskunta KPY Financial ConglomeratesFinance Osuuskunta KPY operates as a long-term investor. It also rents office space and invests in securities. The company was founded in 1883 and is headquartered in Kuopio, Finland. | Director/Board Member | - | - |
Career history of Juha Matti Yrjänheikki
Former positions of Juha Matti Yrjänheikki
Companies | Position | Start | End |
---|---|---|---|
Pharmatest Services Oy
![]() Pharmatest Services Oy Miscellaneous Commercial ServicesCommercial Services Pharmatest Services Oy offers translational research services for diseases with unmet clinical needs. It provides full-service research solutions for early drug development. Its focus is on preclinical efficacy models in the fields of cancer and skeletal diseases ranging from in vitro cell culture assays to in vivo models. In addition, the firm develops model and assay development services for its customers. The company was founded by Jussi Halleen and Pirkko Härkönen in 1998 and is headquartered in Turku, Finland. | Director/Board Member | - | - |
Aurealis Pharma AG
![]() Aurealis Pharma AG Miscellaneous Commercial ServicesCommercial Services Part of Aurealis Oy, Aurealis Pharma AG is a Swiss company that provides scientific research and development services. The company is based in Basel, Switzerland. The company was founded by Juha Matti Yrjänheikki. | Founder | - | - |
Charles River Discovery Research Services Finland Oy
![]() Charles River Discovery Research Services Finland Oy Miscellaneous Commercial ServicesCommercial Services Charles River Discovery Research Services Finland Oy provides non-clinical central nervous system services to the pharmaceutical and biotechnology industries. The company was founded in 1998 and is located in Kuopio, Finland. | Chief Executive Officer | - | - |
Training of Juha Matti Yrjänheikki
University of Eastern Finland | Doctorate Degree |
Statistics
International
Finland | 7 |
Switzerland | 2 |
Operational
Director/Board Member | 4 |
Chief Executive Officer | 2 |
Chairman | 1 |
Sectoral
Commercial Services | 4 |
Finance | 3 |
Health Technology | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Private companies | 6 |
---|---|
Charles River Discovery Research Services Finland Oy
![]() Charles River Discovery Research Services Finland Oy Miscellaneous Commercial ServicesCommercial Services Charles River Discovery Research Services Finland Oy provides non-clinical central nervous system services to the pharmaceutical and biotechnology industries. The company was founded in 1998 and is located in Kuopio, Finland. | Commercial Services |
Pharmatest Services Oy
![]() Pharmatest Services Oy Miscellaneous Commercial ServicesCommercial Services Pharmatest Services Oy offers translational research services for diseases with unmet clinical needs. It provides full-service research solutions for early drug development. Its focus is on preclinical efficacy models in the fields of cancer and skeletal diseases ranging from in vitro cell culture assays to in vivo models. In addition, the firm develops model and assay development services for its customers. The company was founded by Jussi Halleen and Pirkko Härkönen in 1998 and is headquartered in Turku, Finland. | Commercial Services |
Aurealis Oy
![]() Aurealis Oy BiotechnologyHealth Technology Aurealis Oy operates as a biopharmaceutical company which develops treatment method that improves life for chronic inflammation and cancer sufferers. It develops a proprietary technology, which utilizes genetically modulated probiotics that deliver a variety of therapeutic proteins to diseased tissue, thus modulating local immune system and enabling healing. The company was founded by Dirk Weber and Thomas Wirth in 2010 and is headquartered in Kuopio, Finland. | Health Technology |
Nostetta Oy
![]() Nostetta Oy Investment ManagersFinance Nostetta Oy (Nostetta) is a venture capital firm founded in 2013. The firm is headquartered in Kuopio, Finland. | Finance |
Aurealis Pharma AG
![]() Aurealis Pharma AG Miscellaneous Commercial ServicesCommercial Services Part of Aurealis Oy, Aurealis Pharma AG is a Swiss company that provides scientific research and development services. The company is based in Basel, Switzerland. The company was founded by Juha Matti Yrjänheikki. | Commercial Services |
Osuuskunta KPY
![]() Osuuskunta KPY Financial ConglomeratesFinance Osuuskunta KPY operates as a long-term investor. It also rents office space and invests in securities. The company was founded in 1883 and is headquartered in Kuopio, Finland. | Finance |